Journal archive for Google Scholar Robot!
The Neuroscience Journal of Shefaye Khatam
مجله علوم اعصاب شفای خاتم
Home
|
All volumes
|
All issues
|
All articles
Volume 5, Number 2 (2017-4)
P 155: The Roles of Microglia in Neurodegenerative Diseases
P 155: The Roles of Microglia in Neurodegenerative Diseases
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 154: The Role of Inflammation in the Seizure Occurrence
P 154: The Role of Inflammation in the Seizure Occurrence
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 153: Neuroinflammation in Multiple Sclerosis
P 153: Neuroinflammation in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 152: Mesenchymal Stem Cells as a Therapeutic Target in Multiple Sclerosis
P 152: Mesenchymal Stem Cells as a Therapeutic Target in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 151: Clinical Trial in Cell Therapy of Multiple Sclerosis
P 151: Clinical Trial in Cell Therapy of Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 150: The Role of Blood Brain Barrier Restoration in the Multiple Sclerosis
P 150: The Role of Blood Brain Barrier Restoration in the Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 149: Effect of Glycoprotein IIb/IIIa Inhibition on Acute Ischemic Stroke Injuries
P 149: Effect of Glycoprotein IIb/IIIa Inhibition on Acute Ischemic Stroke Injuries
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 148: The Role of Cannabinoids in Ischemia Stroke
P 148: The Role of Cannabinoids in Ischemia Stroke
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 147: Role of Sparstolonin B in Intracerebral Hemorrhage-Induced Inflammatory Brain Injury: Blocking the Formation of TLR2/TLR4 Heterodimer
P 147: Role of Sparstolonin B in Intracerebral Hemorrhage-Induced Inflammatory Brain Injury: Blocking the Formation of TLR2/TLR4 Heterodimer
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 146: The Best New Antiepileptic Drugs to Prevent Orofacial Malformations as Side Effects of Antiepileptic Drugs
P 146: The Best New Antiepileptic Drugs to Prevent Orofacial Malformations as Side Effects of Antiepileptic Drugs
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 145: A Review of Animal Models of Absence Epilepsy
P 145: A Review of Animal Models of Absence Epilepsy
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 144: Sunflower Mannose binding Lectin-Associated Serine Protease Inhibitor-1 (SFMI-1) and -2: Significant Inhibitors of Mannose binding Lectin Pathway which Helps in Multiple Sclerosis Treatment
P 144: Sunflower Mannose binding Lectin-Associated Serine Protease Inhibitor-1 (SFMI-1) and -2: Significant Inhibitors of Mannose binding Lectin Pathway which Helps in Multiple Sclerosis Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 143: The Effect of Platelet Activating Factor on Inflammatory Response in Multiple Sclerosis
P 143: The Effect of Platelet Activating Factor on Inflammatory Response in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 142: Air Pollution's Triggering Role in Tau Protein Hyper Phosphorylation; A Sign of Alzheimer Disease
P 142: Air Pollution's Triggering Role in Tau Protein Hyper Phosphorylation; A Sign of Alzheimer Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 141: Mesenchymal Stem Cells as Treatment in Neuroinflammatory Disease
P 141: Mesenchymal Stem Cells as Treatment in Neuroinflammatory Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 140: Stem Cells in Multiple Sclerosis
P 140: Stem Cells in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 139: Curcumin anti-Inflammatory Effect in Neuroinflammatory Disorders: Prospective and Challenges
P 139: Curcumin anti-Inflammatory Effect in Neuroinflammatory Disorders: Prospective and Challenges
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 138: Improving Neuroplasticity Through Neuroinflammation Pathways as a Therapeutic Goal in the Treatment of Autism
P 138: Improving Neuroplasticity Through Neuroinflammation Pathways as a Therapeutic Goal in the Treatment of Autism
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 137: Central Nervous System Involvement in Systemic Lupus Erythematosus
P 137: Central Nervous System Involvement in Systemic Lupus Erythematosus
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 136: The Role of Blood Brain Barrier in Multiple Sclerosis
P 136: The Role of Blood Brain Barrier in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 135: The Effects of Exercise on Treatment of Neuroinflammatory Disorders
P 135: The Effects of Exercise on Treatment of Neuroinflammatory Disorders
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 134: Use of Zinc in Drugs to Improve Neuroinflammation Disease
P 134: Use of Zinc in Drugs to Improve Neuroinflammation Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 133: Neuroinflammation in Alzheimer ’s Disease
P 133: Neuroinflammation in Alzheimer ’s Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 132: The Role of Depression in Prevention or Therapy of Neuroinflammatory Diseases
P 132: The Role of Depression in Prevention or Therapy of Neuroinflammatory Diseases
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 131: Connection Process Inflammation and Improvement Alzheimer’s Disease
P 131: Connection Process Inflammation and Improvement Alzheimer’s Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 130: The Role of Host T- Cell Lymphocyte in Immunopathogenesis of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis
P 130: The Role of Host T- Cell Lymphocyte in Immunopathogenesis of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 129: The Role of Overexpression Transcription Factor BRN 4 in Multiple Sclerosis
P 129: The Role of Overexpression Transcription Factor BRN 4 in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 128: Sleep Disturbance and Epilepsy: An Inflammatory Pathway
P 128: Sleep Disturbance and Epilepsy: An Inflammatory Pathway
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 127: The Role of CGRP in Dental Pulp Nerve repair
P 127: The Role of CGRP in Dental Pulp Nerve repair
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 126: The Relationship between Bell`s Palsy and Diabetes
P 126: The Relationship between Bell`s Palsy and Diabetes
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 125: Treatment of Multiple Sclerosis with Mesenchymal Cells Starfish
P 125: Treatment of Multiple Sclerosis with Mesenchymal Cells Starfish
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 124: Decrease Signs Parkinson`s Disease with DOPAMINE in Apple
P 124: Decrease Signs Parkinson`s Disease with DOPAMINE in Apple
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 123: A Promising Approach in Inflammation Management, Cytokine Therapy for Alzheimer’s Disease
P 123: A Promising Approach in Inflammation Management, Cytokine Therapy for Alzheimer’s Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 122: Dietary Habits and Multiple Sclerosis
P 122: Dietary Habits and Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 121: Neuroinflammation and Diabetes
P 121: Neuroinflammation and Diabetes
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 120: The Effect of Steroids on the Optic Neuritis in MS
P 120: The Effect of Steroids on the Optic Neuritis in MS
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 119: Role of Gut Bacteria on Alzheimer’s Disease
P 119: Role of Gut Bacteria on Alzheimer’s Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 118: Osteopontin: An Early Player in Neuroinflammation Disease
P 118: Osteopontin: An Early Player in Neuroinflammation Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 117: Endocannabinoid System as a Novel Therapeutic Target in Epilepsy
P 117: Endocannabinoid System as a Novel Therapeutic Target in Epilepsy
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 116: The Effect of Galectin-3 and Lanthionine Ketimine Ester in Neural Recovery after Spinal Cord Injury
P 116: The Effect of Galectin-3 and Lanthionine Ketimine Ester in Neural Recovery after Spinal Cord Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 115: Potential Therapeutic Targets Related to Neuroinflammation in Treatment and Prevention of Autism
P 115: Potential Therapeutic Targets Related to Neuroinflammation in Treatment and Prevention of Autism
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 114: The Impact of Chamomile on Parkinson Disease (PD)
P 114: The Impact of Chamomile on Parkinson Disease (PD)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 113: Effect of Curcumin on Microglial Cells in MS
P 113: Effect of Curcumin on Microglial Cells in MS
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 112: Combining Granulocyte-Colony Stimulating Factor (G-CSF) and Stem Cells in Treatment of Traumatic Brain Injury (TBI)
P 112: Combining Granulocyte-Colony Stimulating Factor (G-CSF) and Stem Cells in Treatment of Traumatic Brain Injury (TBI)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 111: Use of Stem Cell Therapy for Treatment of Temporal Lobe Epilepsy (TLE)
P 111: Use of Stem Cell Therapy for Treatment of Temporal Lobe Epilepsy (TLE)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 110: Evaluating the Role of Histone Hyper Acetylation in Induction of Neuroinflammation
P 110: Evaluating the Role of Histone Hyper Acetylation in Induction of Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 109: The Potential Preventive-Therapeutic Effects of Flavonol Consumption on Alzheimer's Disease
P 109: The Potential Preventive-Therapeutic Effects of Flavonol Consumption on Alzheimer's Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 108: Evaluation of Calcineurin Role in Neuroinflmmation: Possible Targets for Early Detection and Treatment
P 108: Evaluation of Calcineurin Role in Neuroinflmmation: Possible Targets for Early Detection and Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 107: P2x7 Receptors: as a Novel Targets for the Treatment of Neuroinflammation
P 107: P2x7 Receptors: as a Novel Targets for the Treatment of Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 106: Effects of Dimethyl Sulfoxide on NLRP3 Inflammasome and Alzheimer's Disease
P 106: Effects of Dimethyl Sulfoxide on NLRP3 Inflammasome and Alzheimer's Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease
P 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 104: Effects of Human Neural Stem Cells in Cure Neuroinflammation of Traumatic Brain Injury
P 104: Effects of Human Neural Stem Cells in Cure Neuroinflammation of Traumatic Brain Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 103: Effects of Physical Exercise on Neuroinflammation
P 103: Effects of Physical Exercise on Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 102: The Study of Some Factors Which Effect on Beta-Amyloid Signaling in Neuroinflammation
P 102: The Study of Some Factors Which Effect on Beta-Amyloid Signaling in Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 101: Ginger and Honey Mixture as an Anti-Inflammatory Drug in Neuroinflammation:Alzheimer Disease
P 101: Ginger and Honey Mixture as an Anti-Inflammatory Drug in Neuroinflammation:Alzheimer Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 100: Stem Cells as Neuroinflammatory Modulator in TBI: A Narrative Review
P 100: Stem Cells as Neuroinflammatory Modulator in TBI: A Narrative Review
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 99: Self-Assembling Peptide Scaffolds as New Therapeutic Method in TBI: Focused on Bioactive Motifs
P 99: Self-Assembling Peptide Scaffolds as New Therapeutic Method in TBI: Focused on Bioactive Motifs
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 98: Neuroinflammation and Nanomedicine,How about Cerebral Palsy
P 98: Neuroinflammation and Nanomedicine,How about Cerebral Palsy
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 97: Neurodegeneration Induced by Tau protein
P 97: Neurodegeneration Induced by Tau protein
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 96: Role of Thrombin in Inflammatory Central Nervous System (CNS) Diseases
P 96: Role of Thrombin in Inflammatory Central Nervous System (CNS) Diseases
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 95: Result of Alcohol Excessive Drinking in the Brain and Varying Mental Health Side Effects
P 95: Result of Alcohol Excessive Drinking in the Brain and Varying Mental Health Side Effects
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 94: The Systemic Inflammation after Spinal Cord Injury
P 94: The Systemic Inflammation after Spinal Cord Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 93: The Role of Marine Compounds in Neuroinflammation
P 93: The Role of Marine Compounds in Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 92: A Critical Balance between Repair and Demolish of Proinflammatory Factors to Improve Effects of Neuroinflammation
P 92: A Critical Balance between Repair and Demolish of Proinflammatory Factors to Improve Effects of Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 91: The Evaluation of Serum Level of 25-Hydroxy Vitamin D in Patients under Sodium Valproate Medication
P 91: The Evaluation of Serum Level of 25-Hydroxy Vitamin D in Patients under Sodium Valproate Medication
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 90: The Role of miR-146a in Inflammatory Process of Mesial Temporal Lobe Epilepsy (MTLE): Implication for Therapy
P 90: The Role of miR-146a in Inflammatory Process of Mesial Temporal Lobe Epilepsy (MTLE): Implication for Therapy
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 89: Reduction of Neuroinflammation in Epilepsy by Using Stem Cells Derived Astrocytes
P 89: Reduction of Neuroinflammation in Epilepsy by Using Stem Cells Derived Astrocytes
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 88: Matrix Metalloproteinases in Neuroinflammation
P 88: Matrix Metalloproteinases in Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 87: The Amyloid Beta as a Therapeutic Target in Alzheimer Disease
P 87: The Amyloid Beta as a Therapeutic Target in Alzheimer Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 86: CD166 as a Therapeutic Target in Autoimmune Diseases
P 86: CD166 as a Therapeutic Target in Autoimmune Diseases
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 85: Anticonvulsant Activity of the Leaves of Glycyrrhiza-Glabra Var. Glandulifera and Antioxidant Effect of Achillea Wilhelmsii in Epilepsy Treatment
P 85: Anticonvulsant Activity of the Leaves of Glycyrrhiza-Glabra Var. Glandulifera and Antioxidant Effect of Achillea Wilhelmsii in Epilepsy Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 84: Daily Nutrition has a Grand but Inapparent Effect on the Procedure of Inflammatory Dementia
P 84: Daily Nutrition has a Grand but Inapparent Effect on the Procedure of Inflammatory Dementia
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 83: Progression of Hearing Loss in Experimental Meningitis
P 83: Progression of Hearing Loss in Experimental Meningitis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 82: The Transplantation of Human Umbilical Cord Mesenchymal Stem Cells in Neonatal Strokes
P 82: The Transplantation of Human Umbilical Cord Mesenchymal Stem Cells in Neonatal Strokes
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 81: Omega-3 Fatty Acid and Oxylipins in Management of Alzheimer Disease
P 81: Omega-3 Fatty Acid and Oxylipins in Management of Alzheimer Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 80: Effects of Vitamin D on Migraine
P 80: Effects of Vitamin D on Migraine
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 79: Neuroinflammation: A Common Phenomenon between Chronic Pain and Opioids
P 79: Neuroinflammation: A Common Phenomenon between Chronic Pain and Opioids
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 78: The Role of Kynurenine Pathway in Suicidal Behavior and Depression
P 78: The Role of Kynurenine Pathway in Suicidal Behavior and Depression
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 77: The Role of Interleukin-1 in Neurogenesis and Alzheimer Disease
P 77: The Role of Interleukin-1 in Neurogenesis and Alzheimer Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 76: Assay of Alterations of Cytokines to Remedy of Traumatic Brain Injury
P 76: Assay of Alterations of Cytokines to Remedy of Traumatic Brain Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 75: Inflammation in the Pathogenesis of Depression
P 75: Inflammation in the Pathogenesis of Depression
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 74: Neuro-Inflammation and Quality of Life-A Narrative Review
P 74: Neuro-Inflammation and Quality of Life-A Narrative Review
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 73: The Effect of Hypnotherapy and Cognitive Therapy in Management of Multiple Sclerosis Pain
P 73: The Effect of Hypnotherapy and Cognitive Therapy in Management of Multiple Sclerosis Pain
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 72: Serological Changes of Cytokines, in Diagnosing and Treatment Children with Autism
P 72: Serological Changes of Cytokines, in Diagnosing and Treatment Children with Autism
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 71: A Review on the Role and Efficacy of Vitamins in Depression
P 71: A Review on the Role and Efficacy of Vitamins in Depression
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 70: Primary Progressive MS and Affecting Genes
P 70: Primary Progressive MS and Affecting Genes
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 69: Effect of Serum Zinc Element in Epilepsy Paitaints
P 69: Effect of Serum Zinc Element in Epilepsy Paitaints
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 68: The Role of Neuroinflammation in Post-Traumatic Stress Disorder (PTSD)
P 68: The Role of Neuroinflammation in Post-Traumatic Stress Disorder (PTSD)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 67: The Role of Neuroinflammation in Dysfunction of Adult Hippocampal Neurogenesis
P 67: The Role of Neuroinflammation in Dysfunction of Adult Hippocampal Neurogenesis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 66: A Review of Novel Biomarkers Involved in the Neuroinflammation Caused by Human T Lymphotropic Virus-1
P 66: A Review of Novel Biomarkers Involved in the Neuroinflammation Caused by Human T Lymphotropic Virus-1
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 65: Soluble CD18 as an Inflammation Reducing Agent in Parkinson's Disease
P 65: Soluble CD18 as an Inflammation Reducing Agent in Parkinson's Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 64: Micro-Rna Disorder and Multiple Sclerosis
P 64: Micro-Rna Disorder and Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 63: Role of Neuroinflammation in Depression
P 63: Role of Neuroinflammation in Depression
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 62: Markers of Neuroinflammation Related to Alzheimer's Disease Pathology in the Elderly
P 62: Markers of Neuroinflammation Related to Alzheimer's Disease Pathology in the Elderly
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 61: MicroRNA as a Therapeutic Tool to Prevent Blood Brain Barrier Dysfunction in Neuroinflammation
P 61: MicroRNA as a Therapeutic Tool to Prevent Blood Brain Barrier Dysfunction in Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 60: The Effect of Melatonin as a Therapeutic Goal on Multiple Sclerosis Through Immune Processes
P 60: The Effect of Melatonin as a Therapeutic Goal on Multiple Sclerosis Through Immune Processes
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 59: Non-Steroidal Anti-Inflammatory Drugs as a Prevention of Alzheimer Disease: Risks and Benefits
P 59: Non-Steroidal Anti-Inflammatory Drugs as a Prevention of Alzheimer Disease: Risks and Benefits
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 58: Herbal Medicine “Ginseng” as Therapy and Prevention of Parkinson`s Disease
P 58: Herbal Medicine “Ginseng” as Therapy and Prevention of Parkinson`s Disease
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 57: The Effect of Biotin as a Therapeutic Agent for Progressive Multiple Sclerosis
P 57: The Effect of Biotin as a Therapeutic Agent for Progressive Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 56: Inhibitory Effects of Curcumin, a Regulator of CD4+ T Helper Cell, on HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
P 56: Inhibitory Effects of Curcumin, a Regulator of CD4+ T Helper Cell, on HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 55: Sleep Disturbance and Epilepsy: an Inflammatory Pathway
P 55: Sleep Disturbance and Epilepsy: an Inflammatory Pathway
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 54: Migraine: a Brain Plasticity Response to Repetitive Stressful Occurrences
P 54: Migraine: a Brain Plasticity Response to Repetitive Stressful Occurrences
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 53: Stem Cell Therapy for Treatment of Autoimmune Diseases (with Emphasis on Multiple Sclerosis)
P 53: Stem Cell Therapy for Treatment of Autoimmune Diseases (with Emphasis on Multiple Sclerosis)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 52: Interferon beta-a1 vs. Teriflunomide for Multiple Sclerosis
P 52: Interferon beta-a1 vs. Teriflunomide for Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 51: The Role of T Helper 17 in Pathogenesis of Multiple Sclerosis
P 51: The Role of T Helper 17 in Pathogenesis of Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 50: A Review on the Role and Efficacy of Vitamins in Depression
P 50: A Review on the Role and Efficacy of Vitamins in Depression
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 49: Exercise Effects on Cognitive Impairments Through Altering Neuroinflammation
P 49: Exercise Effects on Cognitive Impairments Through Altering Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 48: Pioglitazone in Early Parkinson: A Review Study
P 48: Pioglitazone in Early Parkinson: A Review Study
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 47: Occupational Toxins and Neuroinflammation
P 47: Occupational Toxins and Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 46: The Role of Kv7-Channels in the Pathophysiology of Multiple Sclerosis
P 46: The Role of Kv7-Channels in the Pathophysiology of Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 45: De- and Remyelination Affect Cognitive and Locomotor Abilities in Mice
P 45: De- and Remyelination Affect Cognitive and Locomotor Abilities in Mice
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 44: The Role of HCN Channels in T Cell Function
P 44: The Role of HCN Channels in T Cell Function
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 43: The Role of TWIK2 Channels on Immune Cells and its Impact in EAE/ MS Pathophysiology
P 43: The Role of TWIK2 Channels on Immune Cells and its Impact in EAE/ MS Pathophysiology
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 42: Effect of Hesperetin During Pregnancy and Lactation on Locomotor Activity and Anxiety-Like Behaviors in Animal Model of Autism
P 42: Effect of Hesperetin During Pregnancy and Lactation on Locomotor Activity and Anxiety-Like Behaviors in Animal Model of Autism
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 41: Meningioma Stem Like Cells and Self Assembling Nanopeptide Scaffold for Treatment of Traumatic Brain Injury in Animal Model
P 41: Meningioma Stem Like Cells and Self Assembling Nanopeptide Scaffold for Treatment of Traumatic Brain Injury in Animal Model
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 40: Neuroprotective Effects of Saffron Extract in Rat Brain Under Ischemia Reperfusion Model
P 40: Neuroprotective Effects of Saffron Extract in Rat Brain Under Ischemia Reperfusion Model
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 39: Screening of Anxiety, Depression and Quality of Life in Epileptic Patients and Their Family
P 39: Screening of Anxiety, Depression and Quality of Life in Epileptic Patients and Their Family
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 38: The Relationship between Personality Traits and Cortisol Levels and TGF-B in Patients with Multiple Sclerosis Have Optic Neuritis (Optic Neuritis)
P 38: The Relationship between Personality Traits and Cortisol Levels and TGF-B in Patients with Multiple Sclerosis Have Optic Neuritis (Optic Neuritis)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 37: Prescribing Pepper for Stroke Treatment
P 37: Prescribing Pepper for Stroke Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 36: Protective Effects of Crocin on D-Galactose Induced Aging Model in Human Neuroblastoma Cells
P 36: Protective Effects of Crocin on D-Galactose Induced Aging Model in Human Neuroblastoma Cells
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 35: The Mediating Role of Meta-Cognitive Beliefs on the Cognitive-Executive Functions of Brain, Sleep Disorders, Optic Neuritis in Multiple Sclerosis Patients
P 35: The Mediating Role of Meta-Cognitive Beliefs on the Cognitive-Executive Functions of Brain, Sleep Disorders, Optic Neuritis in Multiple Sclerosis Patients
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 34: Evidence of Panax Ginseng in Multiple Sclerosis
P 34: Evidence of Panax Ginseng in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 33: Effect of Alcoholic Extract of Rosmarinus officinalis L. and Rosmarinic Acid on Inflammation Induced by Chronic Constriction Injury (CCI) Model of Neuropathic Pain in Rats
P 33: Effect of Alcoholic Extract of Rosmarinus officinalis L. and Rosmarinic Acid on Inflammation Induced by Chronic Constriction Injury (CCI) Model of Neuropathic Pain in Rats
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 32: The Role of CB2 Activation in Rats Under Harmaline Toxicity
P 32: The Role of CB2 Activation in Rats Under Harmaline Toxicity
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 31: Reduce Inflammation and Hypothalamic Disorders in Patients with Multiple Sclerosis
P 31: Reduce Inflammation and Hypothalamic Disorders in Patients with Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 30: Effect of Fasudil on Acrylamide-Induced Cytotoxicity in PC12 Cells Through Evaluation of ROS and MTT Test
P 30: Effect of Fasudil on Acrylamide-Induced Cytotoxicity in PC12 Cells Through Evaluation of ROS and MTT Test
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 29: Effects of Different Doses of Some GABAergic Agents in Mouse Brain Under Hypoxic State: Possible Role in Neuro-Inflammation
P 29: Effects of Different Doses of Some GABAergic Agents in Mouse Brain Under Hypoxic State: Possible Role in Neuro-Inflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 28: Bone Marrow-Derived Mesenchymal Stem Cells Reduces Neuroinflammation and Splenic Cytolytic CD8 + T Cells in Mice with Experimental Autoimmune Encephalomyelitis
P 28: Bone Marrow-Derived Mesenchymal Stem Cells Reduces Neuroinflammation and Splenic Cytolytic CD8 + T Cells in Mice with Experimental Autoimmune Encephalomyelitis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 27: The Beneficial Effect of Aminoguanidine on Lipopolysaccharide -Induced Memory Impairment and Neuro-Inflammation in Rats
P 27: The Beneficial Effect of Aminoguanidine on Lipopolysaccharide -Induced Memory Impairment and Neuro-Inflammation in Rats
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 26: The Protective Effect of Nano-Hesperetin on Memory Disorder Induced by Streptozotocinin Male Rat in Alzheimer Models
P 26: The Protective Effect of Nano-Hesperetin on Memory Disorder Induced by Streptozotocinin Male Rat in Alzheimer Models
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 25: The Facilitatory Action of Snake Venom Phospholipase A2 Neurotoxins by Which Increase the Release of Acetylcholine, May Improve Alzheimer's Disease Symptoms
P 25: The Facilitatory Action of Snake Venom Phospholipase A2 Neurotoxins by Which Increase the Release of Acetylcholine, May Improve Alzheimer's Disease Symptoms
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 24: Evaluation of the Voxel Based Morphometry in Quantitative Analysis of Brain MRI Images
P 24: Evaluation of the Voxel Based Morphometry in Quantitative Analysis of Brain MRI Images
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 23: Apoptosis Following Cortical Spreading Depression in Juvenile Rats
P 23: Apoptosis Following Cortical Spreading Depression in Juvenile Rats
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 22: Antihypoxic Effect of Saffron Extract in Mouse Model of Hypoxic Ischemia
P 22: Antihypoxic Effect of Saffron Extract in Mouse Model of Hypoxic Ischemia
|
[Abstract-FA]
|
[Abstract-EN]
|
[XML]
|
P 21: Epidemiology of Multiple Sclerosis in Khorasan Razavi Province
P 21: Epidemiology of Multiple Sclerosis in Khorasan Razavi Province
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 20: Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Glioblastoma Multiforme: a Systematic Review and Meta-Analysis
P 20: Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Glioblastoma Multiforme: a Systematic Review and Meta-Analysis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 19: The Effects of Aloe Vera Extract on Brain Edema and Blood-Brain Barrier Permeability after Traumatic Brain Injury
P 19: The Effects of Aloe Vera Extract on Brain Edema and Blood-Brain Barrier Permeability after Traumatic Brain Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 18: Alterations of Electrophysiological Activity of Cerebellar Pukinje Cells of Rats Under Harmaline Toxicity
P 18: Alterations of Electrophysiological Activity of Cerebellar Pukinje Cells of Rats Under Harmaline Toxicity
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 17: Electrophysiological Effects of Cannabinoid Receptor Antagonist AM251 on Harmaline Toxicity in Rat’s Cerebellar Vermis Slices
P 17: Electrophysiological Effects of Cannabinoid Receptor Antagonist AM251 on Harmaline Toxicity in Rat’s Cerebellar Vermis Slices
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 16: The Effect of Reducing CCL11 on Multiple Sclerosis Treatment by Using Heterochronic Parabiosis Techniques
P 16: The Effect of Reducing CCL11 on Multiple Sclerosis Treatment by Using Heterochronic Parabiosis Techniques
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 15: Forced Exercise Attenuates Neuropathic Pain in Chronic Constriction Injury Male Rat: An Approach to Oxidative Stress and Inflammation
P 15: Forced Exercise Attenuates Neuropathic Pain in Chronic Constriction Injury Male Rat: An Approach to Oxidative Stress and Inflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 14: CSF NGF/IL-6 Ratio: a Useful Marker for the Evaluation of Progesterone Efficacy in Traumatic Brain Injury
P 14: CSF NGF/IL-6 Ratio: a Useful Marker for the Evaluation of Progesterone Efficacy in Traumatic Brain Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 13: Correlation Between Alanine Aminotransferase Serum (ALT) Level and Behavioral Symptoms of 6-Hydroxydopamine (6-OHDA)-Induced Parkinsonism in Rats
P 13: Correlation Between Alanine Aminotransferase Serum (ALT) Level and Behavioral Symptoms of 6-Hydroxydopamine (6-OHDA)-Induced Parkinsonism in Rats
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 12: Study of the Association between Serum Level of Cystatin C and Behavioral Symptoms of 6-Hydroxydopamine – Induced Parkinsonism in Rat
P 12: Study of the Association between Serum Level of Cystatin C and Behavioral Symptoms of 6-Hydroxydopamine – Induced Parkinsonism in Rat
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 11: Terminalia Chebula Attenuates Quinolinate-Induced Oxidative PC12 and OLN-93 Cells Death
P 11: Terminalia Chebula Attenuates Quinolinate-Induced Oxidative PC12 and OLN-93 Cells Death
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 10: Safranal Attenuates Quinolinate-Induced Oxidative OLN-93 Cells Death
P 10: Safranal Attenuates Quinolinate-Induced Oxidative OLN-93 Cells Death
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 9: Neuoprotective Effect of Cannabinoid CB1 Receptor Antagonists Rimonabant and AM251 on Hypoxic Mouse Model of Brain Oxidative Stress
P 9: Neuoprotective Effect of Cannabinoid CB1 Receptor Antagonists Rimonabant and AM251 on Hypoxic Mouse Model of Brain Oxidative Stress
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 8: Affective Factors in the Event Time of Neuropathy in Diabetic Patients (Type II)
P 8: Affective Factors in the Event Time of Neuropathy in Diabetic Patients (Type II)
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 7: The Effect of Curcumin and Melittin on an Animal Model of MS
P 7: The Effect of Curcumin and Melittin on an Animal Model of MS
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 6: Effect of Voluntary Exercise on Learning and Memory Impairments in Sleep Deprived Female Rats
P 6: Effect of Voluntary Exercise on Learning and Memory Impairments in Sleep Deprived Female Rats
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 5: The Effect of Previous Endurance Exercise in Traumatic Brain Injury
P 5: The Effect of Previous Endurance Exercise in Traumatic Brain Injury
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 4: The Hypothesis Detect Multiple Sclerosis in Early Stage with Saliva Testing
P 4: The Hypothesis Detect Multiple Sclerosis in Early Stage with Saliva Testing
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 3: The Study about MRI Images of Encephalitis and Diagnosis by Using the Software Ways
P 3: The Study about MRI Images of Encephalitis and Diagnosis by Using the Software Ways
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 2: Proliferation of Neural Stem Cells Promotes in Presence of Feijoa Methanolic Extract in the Oxidative Stress Condition
P 2: Proliferation of Neural Stem Cells Promotes in Presence of Feijoa Methanolic Extract in the Oxidative Stress Condition
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
P 1: Effect of Clavulanic Acid on Trimethyltin-Induced Cytotoxicity in PC12
P 1: Effect of Clavulanic Acid on Trimethyltin-Induced Cytotoxicity in PC12
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 31: HTLV-1 and Inflammation
O 31: HTLV-1 and Inflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 30: Peripheral Nervous System Diseases and Inflammation
O 30: Peripheral Nervous System Diseases and Inflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 29: Autoimmune Myasthenia Gravis Introduction, Immunopathogenesis and Classification
O 29: Autoimmune Myasthenia Gravis Introduction, Immunopathogenesis and Classification
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 28: Autoimmune Myositis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
O 28: Autoimmune Myositis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 27: Traumatic Brain Injury and Inflammation
O 27: Traumatic Brain Injury and Inflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 26: Treatment of Traumatic Brain Injury in Adult Rats with Injection of Human Epileptic Neural Stem Cells and Nano-Scaffold
O 26: Treatment of Traumatic Brain Injury in Adult Rats with Injection of Human Epileptic Neural Stem Cells and Nano-Scaffold
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 25: Immunotherapy for Brain Tumor
O 25: Immunotherapy for Brain Tumor
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 24: Functional Role of The K2p Potassium Channel Task-3 in A Syngeneic Murine Glioma Model
O 24: Functional Role of The K2p Potassium Channel Task-3 in A Syngeneic Murine Glioma Model
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 23: Anti-Inflammatory Treatment in Children with Refractory Seizure
O 23: Anti-Inflammatory Treatment in Children with Refractory Seizure
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 22: Reactive Oxygen Species and Epilepsy
O 22: Reactive Oxygen Species and Epilepsy
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 21: A Case of Anti-NMDA Receptor Encephalitis Who Presented with Status Epilepticus
O 21: A Case of Anti-NMDA Receptor Encephalitis Who Presented with Status Epilepticus
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 20: The Role of Neuroinflammation in Epilepsy: A New Target for Treatment
O 20: The Role of Neuroinflammation in Epilepsy: A New Target for Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 19: Treatment and Porognosis of Autoimmune Encephalitis
O 19: Treatment and Porognosis of Autoimmune Encephalitis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 18: Autoimmune Dementia
O 18: Autoimmune Dementia
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 17: Childhood Anti-NMDA Receptor Encephalitis
O 17: Childhood Anti-NMDA Receptor Encephalitis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 16: Challenge in Diagnosis and Management of Autoimmune Encephalitis
O 16: Challenge in Diagnosis and Management of Autoimmune Encephalitis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 15: Limbic Encephalitis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
O 15: Limbic Encephalitis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 14: Differentiating Demyelinating Disorders of the Central Nervous System – a Focus on Multiple Sclerosis and Neuromyelitis-Optica Spectrum Disorders
O 14: Differentiating Demyelinating Disorders of the Central Nervous System – a Focus on Multiple Sclerosis and Neuromyelitis-Optica Spectrum Disorders
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 13: Ion Channels in Autoimmune Neurodegeneration
O 13: Ion Channels in Autoimmune Neurodegeneration
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 12: The Pathophysiological Hallmarks of MS Beyond the Blood Brain Barrier: Myelination and Neuronal Network Interactions
O 12: The Pathophysiological Hallmarks of MS Beyond the Blood Brain Barrier: Myelination and Neuronal Network Interactions
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 11: Diagnosis and Management of Neuromyelitis Optica
O 11: Diagnosis and Management of Neuromyelitis Optica
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 10: Multiple Sclerosis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
O 10: Multiple Sclerosis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 9: Immunomodulatory Effects of Neural Stem Cell on Multiple Sclerosis: A Systematic Review
O 9: Immunomodulatory Effects of Neural Stem Cell on Multiple Sclerosis: A Systematic Review
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 8: Tenasin-C as a New Target for Multiple Sclerosis Treatment
O 8: Tenasin-C as a New Target for Multiple Sclerosis Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 7: KCNK2 Regulates the Nanoscale Formation of Immune Docking Structures on Brain Endothelial Cells Under Autoinflammatory Conditions
O 7: KCNK2 Regulates the Nanoscale Formation of Immune Docking Structures on Brain Endothelial Cells Under Autoinflammatory Conditions
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 6: Kininogen Deficiency Ameliorates Neuroinflammation by Reducing Immune Cell Trafficking
O 6: Kininogen Deficiency Ameliorates Neuroinflammation by Reducing Immune Cell Trafficking
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 5: Coagulation Factors in Multiple Sclerosis may Represent Diagnostic and Therapeutic Strategies
O 5: Coagulation Factors in Multiple Sclerosis may Represent Diagnostic and Therapeutic Strategies
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 4: Kynurenine Impairs MbMEC Function in Vitro Through Arylhydrocarbon Receptor Activation
O 4: Kynurenine Impairs MbMEC Function in Vitro Through Arylhydrocarbon Receptor Activation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 3:Therapeutic Potential of a Novel NMDA Receptor Subunit 2B Antagonist in a Mouse Model of Autoimmune Neuroinflammation
O 3:Therapeutic Potential of a Novel NMDA Receptor Subunit 2B Antagonist in a Mouse Model of Autoimmune Neuroinflammation
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 2: Anti-Inflammatory Approach to Epilepsy Treatment
O 2: Anti-Inflammatory Approach to Epilepsy Treatment
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
O 1: The Effects of Vitamin D Supplementation on the T cell Compartment in Multiple Sclerosis
O 1: The Effects of Vitamin D Supplementation on the T cell Compartment in Multiple Sclerosis
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
Abstract Book of The 1st International NeuroinflammationCongress and 1st Student Festival of Neurosience
Abstract Book of the 1st International Neuroinflammation Congress and 1st Student Festival of Neurosience
|
[Abstract-FA]
|
[Abstract-EN]
|
[PDF-FA]
|
[XML]
|
Home
|
All volumes
|
All issues
|
All articles